Synthesis, characterization and study of electrochemical applicability of novel asymmetrically substituted 1,3-dialkyl-1,2,3-benzotriazolium salts for supercapacitor fabrication

Here we report the successful synthesis, fabrication, and testing of novel asymmetrically substituted 1,3-dialkyl-1,2,3-benzotriazolium-based ionic liquids. Their applicability in energy storage is tested as gel polymer electrolytes (ILGPE) immobilized in poly(vinylidene fluoride-co-hexa-fluoropropylene) (PVDF-HFP) copolymer as a solid-state electrolyte in electric double layer capacitors (EDLC). Asymmetrically substituted 1,3-dialkyl-1,2,3-benzotriazolium salts of tetrafluoroborates (BF₄^-) and hexafluorophosphates (PF₆^-) are synthesized by anion exchange metathesis reaction using 1,3-dialkyl-1,2,3-benzotriazolium bromide salts. N-Alkylation followed by quaternization reaction results in dialkyl substitution on 1,2,3-benzotriazole. The synthesized ionic liquids were characterized with ¹H-NMR, ¹³C-NMR, and FTIR spectroscopy. Their electrochemical and thermal properties were studied using cyclic voltammetry, impedance spectroscopy, thermogravimetric analysis, and differential scanning calorimetry. The 4.0 V potential windows obtained for asymmetrically substituted 1,3-dialkyl-1,2,3-benzotriazolium salts of BF₄^- and PF₆^- are promising electrolytes for energy storage. ILGPE tested with symmetrical EDLC with a wide operating window from 0-6.0 V gave an effective specific capacitance of 8.85 F g^-1 at a lower scan rate of 2 mV s^-1, the energy density of 2.9 μW h and 11.2 mW g^-1 power density. The fabricated supercapacitor was employed for lighting red LED (2 V, 20 mA).

Wang resin catalysed sonochemical synthesis of pyrazolo[4,3-d]pyrimidinones and 2,3-dihydroquinazolin-4(1H)-ones: Identification of chorismate mutase inhibitors having effects on Mycobacterium tuberculosis cell viability

The enzyme chorismate mutase (or CM that is vital for the survival of bacteria) is an interesting pharmacological target for the identification of new anti-tubercular agents. The 5,5-disibstituted pyrazolo[4,3-d]pyrimidinone derivatives containing the fragment based on 4-amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide were designed and explored as the potential inhibitors of chorismate mutase. Based on encouraging docking results of two representative molecules evaluated in silico against MtbCM (PDB: 2FP2) the Wang resin catalysed sonochemical synthesis of target N-heteroarenes were undertaken. The methodology involved the reaction of 4-amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide with the appropriate cyclic/acyclic ketones to afford the desired products in acceptable (51-94%) yields. The methodology was also extended successfully towards the synthesis of 2,2-disubstituted 2,3-dihydroquinazolin-4(1H)-ones in excellent (85-90%) yields. In vitro MTT assay against the RAW 264.7 cell line followed by enzymatic assay against MtbCM identified 3b and 3c as active compounds that showed two H-bonding via their NH (at position 6) and CO group with MtbCM in silico and encouraging (54-57%) inhibition at 30 µM in vitro. Notably, none of the 2,2-disubstituted 2,3-dihydroquinazolin-4(1H)-ones showed any significant inhibition of MtbCM suggesting the favourable role of the pyrazole moiety in case of pyrazolo[4,3-d]pyrimidinones. The favourable role of cyclopentyl ring attached to the pyrazolo[4,3-d]pyrimidinone moiety and that of two methyl groups in place of cyclopentyl ring was also indicated by the SAR study. Besides showing effects against MtbCM in the concentration response study, 3b and 3c showed little or no effects on mammalian cell viability up to 100 µM in an MTT assay but decreased the % Mtb cell viability at 10-30 µM with > 20% decrease at 30 µM in an Alamar Blue Assay. Moreover, no adverse effects were noted for these compounds when tested for teratogenicity and hepatotoxicity in zebrafish at various concentrations. Overall, being the only example of MtbCM inhibitors that showed effects on Mtb cell viability the compound 3b and 3c are of further interest form the view point of discovery and development of new anti-tubercular agents.

2,3-Dihydroquinazolin-4(1H)-one as a privileged scaffold in drug design

2,3-Dihydroquinazolin-4-one (DHQ) belongs to the class of nitrogen-containing heterocyclic compounds representing a core structural component in various biologically active compounds. In the past decades, several methodologies have been developed for the synthesis of the DHQ framework, especially the 2-substituted derivatives. Unfortunately, multistep syntheses, harsh reaction conditions, and the use of toxic reagents and solvents have limited their full potential as a versatile fragment. Recently, use of green chemistry and alternative strategies are being explored to prepare diverse DHQ derivatives. This fragment is used as a synthon for the preparation of biologically active quinazolinones and as a functional substrate for the synthesis of modified DHQ derivatives exhibiting different biological properties. In this review, we provide a comprehensive assessment of the synthesis and biological evaluations of DHQ derivatives.

Synthesis of benzo[4,5]imidazo[1,2-a]pyrimidines and 2,3-dihydroquinazolin-4(1H)-ones under metal-free and solvent-free conditions for minimizing waste generation

Brønsted acidic ionic liquid was found to be an efficient and recyclable catalyst for the synthesis of benzo[4,5]imidazo[1,2-a]pyrimidines and 2,3-dihydroquinazolin-4(1H)-ones. The reactions proceeded smoothly with a broad scope of substrates providing the expected products in good to excellent yields under an atom-economical pathway. The low-cost recyclable catalyst, metal- and solvent-free conditions, and the ease of product isolation are the highlighted advantages in solving the issue of trace metal contamination in synthesized pharmaceuticals.

A facile, efficient, and atom-economic method for preparing benzo[4,5]imidazo[1,2-a]pyrimidines and 2,3-dihydroquinazolin-4(1H)-ones under metal- and solvent-free condition has been developed.

Ethanol promoted titanocene Lewis acid catalyzed synthesis of quinazoline derivatives

An efficient strategy to activate air-stable Lewis acid precursor Cp₂TiCl₂ with alcoholic solvent for the rapid synthesis of quinazoline derivatives.